Note : les liens hypertextes menant vers d'autres sites ne sont pas mis à jour de façon continue. Il est possible qu'un lien devienne introuvable. Veuillez alors utiliser les outils de recherche pour retrouver l'information désirée.
Bibliographie
Fondation des soins urologie. Adult conditions, Prostate – BPH Topics, UrologyHealth.org. [Consulté le 2 août 2011]. www.urologyhealth.org Ask DrWeil, Polaris Health (Ed). Health Centers, Men’s Health – Benign Prostatic Hyperplasia, DrWeil.com. [Consulté le 2 août 2011]. www.drweil.com Blumenthal M, Goldberg A, Brinckmann J (Ed). Expanded Commission E Monographs, American Botanical Council, publié en collaboration avec Integrative Medicine Communications, États-Unis, 2000. Ernst E, Pittler MH et Wider B (Ed). The Desktop Guide to Complementary and Alternative Medicine : an evidence-based approach, Mosby Elsevier, Angleterre, 2006. Mayo Foundation for Medical Education and Research (Ed). Diseases & Conditions - Prostate gland enlargement, MayoClinic.com. [Consulté le 2 août 2011]. www.mayoclinic.com National Library of Medicine (Ed). PubMed, NCBI. [Consulté le 2 août 2011]. www.ncbi.nlm.nih.gov Natural Standard (Ed). Condition Center - Benign prostatic hyperplasia, Nature Medicine Quality Standards. [Consulté le 2 août 2011]. www.naturalstandard.com Pizzorno JE Jr, Murray Michael T (Ed). Textbook of Natural Medicine, Churchill Livingstone, États-Unis, 2006. Saad F, M.D. et McCormack, M.D., urologues, CHUM. Hypertrophie bénigne de la prostate [Consulté le 2 août 2011]. http://web.me.com/ Schulz V, Hänsel R, Tyler VE. Rational Phytotherapy - A Physicians' Guide to Herbal Medicine, fourth edition, Springer, Allemagne, 2001. The Natural Pharmacist (Ed). Conditions - Benign prostatic hyperplasia, ConsumerLab.com. [Consulté le 2 août 2011]. www.consumerlab.com UpToDate. Benign prostatic hyperplasia (BPH). [Consulté le 2 août 2011]. www.uptodate.com
Notes
1. Moyad MA, Lowe FC. Educating patients about lifestyle modifications for prostate health. Am J Med. 2008 Aug;121(8 Suppl 2):S34-42. Review. 2. Lagiou A, Samoli E, et al. Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia. Eur J Cancer Prev. 2008 Aug;17(4):336-9. 3. Parsons JK, Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol. 2008 Jun;53(6):1228-35. 4. Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol. 2007 Aug;178(2):395-401. Epub 2007 Jun 11. Review. 5. Dal Maso L, Zucchetto A, et al. Lifetime occupational and recreational physical activity and risk of benign prostatic hyperplasia. Int J Cancer. 2006 May 15;118(10):2632-5. 6. Brawer MK. Testosterone replacement in men with andropause : an overview. Rev Urol. 2004;6 Suppl 6:S9-S15. Texte intégral : www.pubmedcentral.nih.gov 7. Thompson IM, Goodman PJ, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003 Jul 17;349(3):215-24. Epub 2003 Jun 24. 8. Wilt TJ, Ishani A, et al. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.JAMA 1998 Nov 11;280(18):1604-9. 9. Boyle P, Robertson C, et al. Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia.Urology 2000 Apr;55(4):533-9. 10. Gordon AE, Shaughnessy AF. Saw palmetto for prostate disorders. Am Fam Physician. 2003 Mar 15;67(6):1281-3. Review. Texte intégral : www.aafp.org 11. Boyle P, Robertson C, et al. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. BJU Int. 2004 Apr;93(6):751-6. 12. Gerber GS, Fitzpatrick JM. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia. BJU Int. 2004 Aug;94(3):338-44. Review. 13. Buck AC. Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action. J Urol. 2004 Nov;172(5 Pt 1):1792-9. Review. 14. Fong YK, Milani S, Djavan B. Role of phytotherapy in men with lower urinary tract symptoms. Curr Opin Urol. 2005 Jan;15(1):45-8. Review. 15. Bent S, Kane C, et al. Saw palmetto for benign prostatic hyperplasia.N Engl J Med. 2006 Feb 9;354(6):557-66. 17. Wilt T, Ishani A, et al. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev 2002;(1):CD001044. 18. Ask DrWeil, Polaris Health (Ed). Health Centers, Men’s Health – Benign Prostatic Hyperplasia, DrWeil.com. [Consulté le 2 août 2011]. www.drweil.com 19. Ishani A, MacDonald R, et al. Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis. Am J Med 2000 Dec 1;109(8):654-64. 20. Wilt T, Ishani A, et al. Beta-sitosterols for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2000;(2):CD001043. Review. 21. Preuss HG, Marcusen C, et al. Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH). Int Urol Nephrol. 2001;33(2):217-25. 22. Vontobel HP, Herzog R, et al. [Results of a double-blind study on the effectiveness of ERU (extractum radicis Urticae) capsules in conservative treatment of benign prostatic hyperplasia].Urologe A 1985 Jan;24(1):49-51. 23. Schulz V, Hänsel R, Tyler VE. Rational Phytotherapy - A Physicians' Guide to Herbal Medicine, fourth edition, Springer, Allemagne, 2001, p. 274-275. 24. Ernst Edzard (Ed). The Desktop Guide to Complementary and Alternative Medicine, Mosby, Grande-Bretagne, 2001, p. 138-139. 25. Safarinejad MR. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study. J Herb Pharmacother. 2005;5(4):1-11. 26. Schneider T, Rubben H. [Stinging nettle root extract (Bazoton-uno) in long term treatment of benign prostatic syndrome (BPS). Results of a randomized, double-blind, placebo controlled multicenter study after 12 months][Article en allemand, résumé en anglais]. Urologe A. 2004 Mar;43(3):302-6. 27. Metzker H, Kieser M, Hölscher U. Wirksamkeit eines Sabal-Urtica-kombinationspraparates bei der behandlung der benignen prostatahyperplasie (BPH). Urologe 1996;36(4):292-300. Étude mentionnée et détaillée dans : Natural Standard (Ed). Herbs & Supplements - Saw palmetto, Nature Medicine Quality Standard. [Consulté le 2 août 2011]. www.naturalstandard.com 28. Lopatkin N, Sivkov A, et al. Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms--a placebo-controlled, double-blind, multicenter trial. World J Urol. 2005 Jun;23(2):139-46. 29. Wilt T, Mac Donald R, et al. Cernilton for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2000;(2):CD001042. Review. 30. Jonas A, Rosenblat G, et al. Cactus flower extracts may prove beneficial in benign prostatic hyperplasia due to inhibition of 5alpha reductase activity, aromatase activity and lipid peroxidation. Urol Res 1998;26(4):265-70. 31. Pizzorno JE Jr, Murray Michael T (Ed). Textbook of Natural Medicine, Churchill Livingstone, États-Unis, 2006, p. 1550-1551. 32. Ernst E, Pittler MH et Wider B (Ed). The Desktop Guide to Complementary and Alternative Medicine : an evidence-based approach, Mosby Elsevier, Angleterre, 2006. 33. Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Hong H, Kim CS, Maeng S. Nutr Res Pract. 2009 Winter;3(4):323-7. 34. Sokeland J, Albrecht J. [Combination of Sabal and Urtica extract vs. finasteride in benign prostatic hyperplasia (Aiken stages I to II). Comparison of therapeutic effectiveness in a one year double-blind study]Urologe A. 1997 Jul;36(4):327-33. German. 35. Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin. Engelmann U, Walther C, et al. Arzneimittelforschung. 2006;56(3):222-9.
